{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:56:58Z","timestamp":1791899818076,"version":"4.3.4"},"reference-count":41,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dosing of enzyme replacement therapy (ERT) for Gaucher disease type 1 is still a subject of debate and varies from 15 to 130 U\/kg\/mo, making a huge economic difference of US $70 000 to US $380 000 (\u20ac55 000-300 000) per patient per year. To investigate whether this difference in dosing ultimately translates into a different response, we retrospectively compared long-term outcome of ERT at 2 large European treatment centers, Academic Medical Center, Amsterdam, The Netherlands (n = 49, median dose, 15-30 U\/kg\/4 wks) and Heinrich-Heine University, Duesseldorf, Germany (n = 57, median dose, 80 U\/kg\/4 wks). These adult cohorts had a similar genetic background. All follow-up parameters were matched separately at baseline, to avoid bias with respect to disease severity. Improvement in hemoglobin, platelet count, and hepatosplenomegaly was not significantly different between both cohorts, whereas plasma chitotriosidase and bone marrow involvement by magnetic resonance imaging improved more quickly and was more pronounced in the higher-dosed group. Major bone complications rarely occurred in both groups. In conclusion, different dosing regimens of ERT do not affect outcome of hematologic and visceral parameters, but higher dosing leads to accelerated decrease of chitotriosidase and better objective bone response in adult type 1 Gaucher disease.<\/jats:p>","DOI":"10.1182\/blood-2005-12-5072","type":"journal-article","created":{"date-parts":[[2006,3,10]],"date-time":"2006-03-10T01:48:56Z","timestamp":1141955336000},"page":"830-835","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":118,"title":["Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis"],"prefix":"10.1182","volume":"108","author":[{"given":"Maaike","family":"de Fost","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E. M.","family":"Hollak","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna E. M.","family":"Groener","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M. F. G.","family":"Aerts","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maas","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger W.","family":"Poll","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike G.","family":"Wiersma","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Ha\u0308ussinger","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Brett","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brill","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan vom","family":"Dahl","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Endocrinology and Metabolism; Department of Biochemistry; and Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands; Department of Gastroenterology; Hepatology and Infectious Diseases; and Department of Radiology, Heinrich-Heine University, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111711333277400_REF1","doi-asserted-by":"crossref","unstructured":"Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides, II; evidence of an enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun. 1965;18: 221-225.","DOI":"10.1016\/0006-291X(65)90743-6"},{"key":"2019111711333277400_REF2","doi-asserted-by":"crossref","unstructured":"Patrick AD. Short communications: a deficiency of glucocerebrosidase in Gaucher's disease. Biochem J. 1965;97: 17C-18C.","DOI":"10.1042\/bj0970017C"},{"key":"2019111711333277400_REF3","doi-asserted-by":"crossref","unstructured":"Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci U S A. 1990;87: 1913-1916.","DOI":"10.1073\/pnas.87.5.1913"},{"key":"2019111711333277400_REF4","doi-asserted-by":"crossref","unstructured":"Weinreb NJ, Charrow J, Andersson HC, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med. 2002;113: 112-119.","DOI":"10.1016\/S0002-9343(02)01150-6"},{"key":"2019111711333277400_REF5","doi-asserted-by":"crossref","unstructured":"Hollak CE, Aerts JM, Goudsmit R, et al. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease. Lancet. 1995;345: 1474-1478.","DOI":"10.1016\/S0140-6736(95)91037-9"},{"key":"2019111711333277400_REF6","doi-asserted-by":"crossref","unstructured":"Barton NW, Brady RO, Dambrosia JM, et al. Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med. 1991;324: 1464-1470.","DOI":"10.1056\/NEJM199105233242104"},{"key":"2019111711333277400_REF7","doi-asserted-by":"crossref","unstructured":"Elstein D, Hadas-Halpern I, Itzchaki M, et al. Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement. Blood Cells Mol Dis. 1996;22: 104-111.","DOI":"10.1006\/bcmd.1996.0016"},{"key":"2019111711333277400_REF8","doi-asserted-by":"crossref","unstructured":"Figueroa ML, Rosenbloom BE, Kay AC, et al. A less costly regimen of alglucerase to treat Gaucher's disease. N Engl J Med. 1992;327: 1632-1636.","DOI":"10.1056\/NEJM199212033272304"},{"key":"2019111711333277400_REF9","doi-asserted-by":"crossref","unstructured":"Pastores GM, Sibille AR, Grabowski GA. Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood. 1993;82: 408-416.","DOI":"10.1182\/blood.V82.2.408.408"},{"key":"2019111711333277400_REF10","doi-asserted-by":"crossref","unstructured":"Zimran A, Hadas-Halpern I, Zevin S, Levy-Lahad E, Abrahamov A. Low-dose high-frequency enzyme replacement therapy for very young children with severe Gaucher disease. Br J Haematol. 1993;85: 783-786.","DOI":"10.1111\/j.1365-2141.1993.tb03224.x"},{"key":"2019111711333277400_REF11","doi-asserted-by":"crossref","unstructured":"Zimran A, Elstein D, Kannai R, et al. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med. 1994;97: 3-13.","DOI":"10.1016\/0002-9343(94)90042-6"},{"key":"2019111711333277400_REF12","doi-asserted-by":"crossref","unstructured":"Beutler E. Enzyme replacement in Gaucher disease. PLoS Med. 2004;1: e21.","DOI":"10.1371\/journal.pmed.0010021"},{"key":"2019111711333277400_REF13","doi-asserted-by":"crossref","unstructured":"Altarescu G, Schiffmann R, Parker CC, et al. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease. Blood Cells Mol Dis. 2000;26: 285-290.","DOI":"10.1006\/bcmd.2000.0310"},{"key":"2019111711333277400_REF14","doi-asserted-by":"crossref","unstructured":"Ida H, Rennert OM, Kato S, et al. Severe skeletal complications in Japanese patients with type 1 Gaucher disease. J Inherit Metab Dis. 1999;22: 63-73.","DOI":"10.1023\/A:1005451300167"},{"key":"2019111711333277400_REF15","doi-asserted-by":"crossref","unstructured":"Rosenthal DI, Doppelt SH, Mankin HJ, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics. 1995;96: 629-637.","DOI":"10.1542\/peds.96.4.629"},{"key":"2019111711333277400_REF16","doi-asserted-by":"crossref","unstructured":"Weinreb NJ, Aggio MC, Andersson HC, et al. Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin Hematol. 2004;41: 15-22.","DOI":"10.1053\/j.seminhematol.2004.07.010"},{"key":"2019111711333277400_REF17","doi-asserted-by":"crossref","unstructured":"Pastores GM, Weinreb NJ, Aerts H, et al. Therapeutic goals in the treatment of Gaucher disease. Semin Hematol. 2004;41: 4-14.","DOI":"10.1053\/j.seminhematol.2004.07.009"},{"key":"2019111711333277400_REF18","doi-asserted-by":"crossref","unstructured":"Charrow J, Andersson HC, Kaplan P, et al. Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations. J Pediatr. 2004;144: 112-120.","DOI":"10.1016\/j.jpeds.2003.10.067"},{"key":"2019111711333277400_REF19","doi-asserted-by":"crossref","unstructured":"Beutler E. Dosage-response in the treatment of Gaucher disease by enzyme replacement therapy. Blood Cells Mol Dis. 2000;26: 303-306.","DOI":"10.1006\/bcmd.2000.0311"},{"key":"2019111711333277400_REF20","doi-asserted-by":"crossref","unstructured":"Beutler E, Demina A, Laubscher K, et al. The clinical course of treated and untreated Gaucher disease: a study of 45 patients. Blood Cells Mol Dis. 1995;21: 86-108.","DOI":"10.1006\/bcmd.1995.0012"},{"key":"2019111711333277400_REF21","doi-asserted-by":"crossref","unstructured":"Zimran A, Elstein D, Levy-Lahad E, et al. Replacement therapy with imiglucerase for type 1 Gaucher's disease. Lancet. 1995;345: 1479-1480.","DOI":"10.1016\/S0140-6736(95)91038-7"},{"key":"2019111711333277400_REF22","doi-asserted-by":"crossref","unstructured":"Daniels LB, Glew RH. beta-Glucosidase assays in the diagnosis of Gaucher's disease. Clin Chem. 1982;28: 569-577.","DOI":"10.1093\/clinchem\/28.4.569"},{"key":"2019111711333277400_REF23","doi-asserted-by":"crossref","unstructured":"Zimran A, Kay A, Gelbart T, et al. Gaucher disease: clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine. 1992;71: 337-353.","DOI":"10.1097\/00005792-199211000-00002"},{"key":"2019111711333277400_REF24","doi-asserted-by":"crossref","unstructured":"Heymsfield SB, Fulenwider T, Nordlinger B, et al. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med. 1979;90: 185-187.","DOI":"10.7326\/0003-4819-90-2-185"},{"key":"2019111711333277400_REF25","doi-asserted-by":"crossref","unstructured":"Breiman RS, Beck JW, Korobkin M, et al. Volume determinations using computed tomography. AJR Am J Roentgenol. 1982;138: 329-333.","DOI":"10.2214\/ajr.138.2.329"},{"key":"2019111711333277400_REF26","doi-asserted-by":"crossref","unstructured":"Bluemke DA, Fishman EK. Spiral CT of the liver. AJR Am J Roentgenol. 1993;160: 787-792.","DOI":"10.2214\/ajr.160.4.8456666"},{"key":"2019111711333277400_REF27","doi-asserted-by":"crossref","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease. J Clin Invest. 1994;93: 1288-1292.","DOI":"10.1172\/JCI117084"},{"key":"2019111711333277400_REF28","doi-asserted-by":"crossref","unstructured":"Boot RG, Renkema GH, Verhoek M, et al. The human chitotriosidase gene: nature of inherited enzyme deficiency. J Biol Chem. 1998;273: 25680-25685.","DOI":"10.1074\/jbc.273.40.25680"},{"key":"2019111711333277400_REF29","unstructured":"Giraldo P, Cenarro A, Alfonso P, et al. Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers). Haematologica. 2001;86: 977-984."},{"key":"2019111711333277400_REF30","doi-asserted-by":"crossref","unstructured":"Maas M, van Kuijk C, Stoker J, et al. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging\u2013initial experience. Radiology. 2003;229: 554-561.","DOI":"10.1148\/radiol.2292020296"},{"key":"2019111711333277400_REF31","doi-asserted-by":"crossref","unstructured":"Maas M, Hollak CE, Akkerman EM, et al. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR Am J Roentgenol. 2002;179: 961-965.","DOI":"10.2214\/ajr.179.4.1790961"},{"key":"2019111711333277400_REF32","doi-asserted-by":"crossref","unstructured":"Cabrera-Salazar MA, O'Rourke E, Henderson N, Wessel H, Barranger JA. Correlation of surrogate markers of Gaucher disease: implications for long-term follow up of enzyme replacement therapy. Clin Chim Acta. 2004;344: 101-107.","DOI":"10.1016\/j.cccn.2004.02.018"},{"key":"2019111711333277400_REF33","doi-asserted-by":"crossref","unstructured":"Deegan PB, Moran MT, McFarlane I, et al. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells Mol Dis. 2005;35: 259-267.","DOI":"10.1016\/j.bcmd.2005.05.005"},{"key":"2019111711333277400_REF34","doi-asserted-by":"crossref","unstructured":"Boot RG, Renkema GH, Strijland A, van Zonneveld AJ, Aerts JM. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem. 1995;270: 26252-26256.","DOI":"10.1074\/jbc.270.44.26252"},{"key":"2019111711333277400_REF35","doi-asserted-by":"crossref","unstructured":"Vom Dahl S, Poll LW, Haussinger D. Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher. Br J Haematol. 2001;113: 1084-1087.","DOI":"10.1046\/j.1365-2141.2001.02821-9.x"},{"issue":"suppl 2","key":"2019111711333277400_REF36","first-page":"97","volume":"24","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"2019111711333277400_REF37","doi-asserted-by":"crossref","unstructured":"Cremin BJ, Davey H, Goldblatt J. Skeletal complications of type I Gaucher disease: the magnetic resonance features. Clin Radiol. 1990;41: 244-247.","DOI":"10.1016\/S0009-9260(05)81657-5"},{"key":"2019111711333277400_REF38","doi-asserted-by":"crossref","unstructured":"Hermann G, Shapiro RS, Abdelwahab IF, Grabowski G. MR imaging in adults with Gaucher disease type I: evaluation of marrow involvement and disease activity. Skeletal Radiol. 1993;22: 247-251.","DOI":"10.1007\/BF00197668"},{"key":"2019111711333277400_REF39","doi-asserted-by":"crossref","unstructured":"Rosenthal DI, Scott JA, Barranger J, et al. Evaluation of Gaucher disease using magnetic resonance imaging. J Bone Joint Surg Am. 1986;68: 802-808.","DOI":"10.2106\/00004623-198668060-00002"},{"key":"2019111711333277400_REF40","doi-asserted-by":"crossref","unstructured":"Johnson LA, Hoppel BE, Gerard EL, et al. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology. 1992;182: 451-455.","DOI":"10.1148\/radiology.182.2.1732964"},{"key":"2019111711333277400_REF41","doi-asserted-by":"crossref","unstructured":"Rosenthal DI, Barton NW, McKusick KA, et al. Quantitative imaging of Gaucher disease. Radiology. 1992;185: 841-845.","DOI":"10.1148\/radiology.185.3.1438773"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/3\/830\/1282658\/zh801506000830.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/3\/830\/1282658\/zh801506000830.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T18:24:27Z","timestamp":1683397467000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/108\/3\/830\/22363\/Superior-effects-of-highdose-enzyme-replacement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-12-5072","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}